Latest news
23-Apr-2008
Taj Pharmaceuticals Limited
announces 20% average reduction in price of malaria drug
Moartem® to further accelerate access in malaria-endemic
regions
21-Apr-2008
Taj Pharmaceuticals Limited
reports higher sales and earnings in first quarter of
2008 showing healthcare portfolio well on the way to new
growth cycle
15-Apr-2008
FTY720, a novel oral therapy in
development for MS, shows sustained benefits for the
majority of patients after three years of treatment